CLINICAL_TRIALS
research
· 2025-09-05
Clinical Trial Update: WMT for Autism Spectrum Disorder (ASD) [Phase 1]
Summary
This document reports an ongoing Phase 1 clinical trial evaluating WMT for autism spectrum disorder, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Second Hospital of Nanjing Medical University | Conditions: Autism Spectrum Disorder | Phase 1 | Status: RECRUITING